Praxis Precision Medicines, a Phase 2 biotech developing therapies for CNS disorders using genetic insights, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The ...
Taysha Gene Therapies, an early stage biotech developing AAV-based gene therapies for CNS disorders, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. Founded ...
NEW YORK, Oct. 28, 2020 /PRNewswire/ -- AiCure, an AI and advanced data analytics company focused on improving clinical trials, today introduced OpenDBM, an open-source version of its computer vision ...
CHICAGO, IL / ACCESSWIRE / December 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback